Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Work In Process (2016 - 2019)

Aptevo Therapeutics (APVO) has disclosed Work In Process for 5 consecutive years, with $2.0 million as the latest value for Q4 2019.

  • Quarterly Work In Process rose 113.76% to $2.0 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2019, up 113.76% year-over-year, with the annual reading at $2.0 million for FY2019, 113.76% up from the prior year.
  • Work In Process hit $2.0 million in Q4 2019 for Aptevo Therapeutics, down from $5.5 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $5.9 million in Q2 2019 to a low of $4000.0 in Q4 2016.
  • Historically, Work In Process has averaged $2.5 million across 5 years, with a median of $1.8 million in 2016.
  • Biggest five-year swings in Work In Process: crashed 99.92% in 2016 and later soared 11950.0% in 2017.
  • Year by year, Work In Process stood at $4.7 million in 2015, then plummeted by 99.92% to $4000.0 in 2016, then skyrocketed by 11950.0% to $482000.0 in 2017, then skyrocketed by 90.04% to $916000.0 in 2018, then soared by 113.76% to $2.0 million in 2019.
  • Business Quant data shows Work In Process for APVO at $2.0 million in Q4 2019, $5.5 million in Q3 2019, and $5.9 million in Q2 2019.